Blinded by the light: Irofulven chemotherapy trials
Blinded by the light: Irofulven chemotherapy trials
By JACQUELINE STRAX December 16, 2005 /PSA Rising/ The chemotherapy drug Irofulven, a drug based on a poison in the jack o’lantern fungi, is in clinical trials in the USA, Canada and Europe for prostate, ovarian, hepatic and other cancers. A surprising side effect is retinal damage.
No Comments
You must be logged in to post a comment.